Vassilios Papadopoulos will step in as interim dean of the Keck School of Medicine, bringing over a decade of administrative experience from Georgetown and McGill Universities. This strategic appointment is a primary component of a comprehensive leadership restructuring across the university’s healthcare and medical education sectors, set to commence on September 24, 2026. The shift aims to unify the clinical and academic branches of the university’s health enterprise, fostering a more collaborative environment for scientific discovery and patient care. By centralizing oversight, the university intends to create a more agile organization capable of responding to the complex demands of a modern healthcare market. This reorganization is not merely an administrative shuffle but a calculated effort to enhance the synergy between laboratory research and clinical application, ensuring that patients benefit more quickly from medical breakthroughs while students receive an education grounded in the latest healthcare practices.
The Objective: Unifying Clinical and Academic Oversight
Rodney Hanners, who presided over Keck Medicine of USC as Chief Executive Officer for six years, is departing his role as part of this broader organizational evolution. Hanners is widely credited with significantly expanding the system’s regional footprint, successfully extending specialized care into areas such as Pasadena and the San Gabriel Valley. His tenure was defined by a strong focus on clinical excellence and a deep commitment to the professional well-being of the healthcare workforce. He championed the “Care for the Caregiver” program, which provided essential mental health support and resources to medical professionals facing high-pressure environments. His leadership helped establish Keck Medicine as a trusted healthcare provider for diverse communities across the region. As he transitions out of this role, the university plans to build upon the foundation of growth and community trust he established over the past six years.
Steven Shapiro, the current Senior Vice President for Health Affairs, will assume direct operational authority as the new Executive Vice President for the integrated medical enterprise. This newly created role combines the oversight of clinical operations at Keck Medicine with the academic and research missions of the Keck School of Medicine. Shapiro brings a wealth of experience to this position, having previously managed a massive healthcare network involving dozens of hospitals at a major university medical center. By placing both the medical school and the health system under a single executive, the university aims to eliminate institutional silos that can often hinder the translation of research into clinical practice. This consolidated model is expected to provide a more streamlined decision-making process, allowing the university to allocate resources more effectively and respond with greater flexibility to the emerging challenges of the global healthcare and research industries.
Institutional Transition: Continuity at the Keck School
The academic side of the enterprise is also entering a period of transition with the upcoming departure of Dean Carolyn Meltzer, who has led the Keck School of Medicine for the past four years. Meltzer is leaving the deanship to serve as the president of the Radiological Society of North America, a prestigious global role that reflects her significant standing in the international medical community. Despite stepping down from her administrative post, she will remain an integral member of the university as a tenured faculty member within the Department of Radiology and the Alfred E. Mann Department of Biomedical Engineering. Her leadership at the medical school was characterized by a commitment to ethical standards and a successful effort to recruit elite faculty members. She played a pivotal role in expanding the school’s influence through its presence at the USC Capital Campus, ensuring that the institution’s research and educational programs remained competitive on a national scale.
To maintain momentum during this leadership change, the university has turned to Dean Vassilios Papadopoulos to provide steady guidance for the Keck School of Medicine in an interim capacity. While he continues to lead the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, his background in managing complex health science programs at Georgetown and McGill Universities makes him an ideal choice for this role. His appointment ensures that the school’s research initiatives and clinical training programs continue without interruption as the search for a permanent dean begins. This interim leadership is tasked with upholding the high standards of academic excellence that Meltzer fostered while beginning to implement the new integrated management model. The university’s focus remains on finding a permanent leader who can bridge the gap between academic discovery and clinical care, ensuring that the school continues to produce world-class medical professionals and groundbreaking scientific research.
Strategic Implementation: Enhancing Operations and Future Care
Complementing the senior executive changes, other key leaders are taking on expanded responsibilities to ensure the stability and growth of the medical enterprise. David Peng, who currently serves as the Chief Clinical Officer, will now also take on the role of Deputy Executive Vice President for Health Affairs. His focus will be on bridging the gap between clinical practice and medical education, particularly as the Keck Community Medical Group continues its strategic expansion throughout the region. Simultaneously, Marty Sargeant will transition into the role of Chief Operating Officer for Keck Medicine while retaining his position as CEO of the medical center. This structure ensures that hospital operations and the delivery of complex medical care remain efficient and patient-centered. By empowering these experienced internal leaders, the university is signaling its intent to maintain a high level of operational continuity and regional growth during this period of significant administrative restructuring.
The administrative reorganization initiated in late 2026 successfully established a more cohesive management framework for the university’s expansive medical system. By centralizing leadership and clarifying reporting lines, the institution moved to eliminate the inefficiencies associated with fragmented oversight. The transition allowed for a more direct alignment between the university’s academic research goals and its clinical service delivery, providing a clear path for future innovation. Moving forward, the university focused on conducting a comprehensive search for a permanent dean who could leverage this new integrated structure to further elevate the school’s international standing. Stakeholders were encouraged to view these changes as a commitment to long-term stability and a more focused approach to addressing the healthcare needs of the community. The shift ultimately created a more resilient and unified medical enterprise, better prepared to meet the clinical and educational challenges of the coming decade with increased precision and excellence.
